ClinicalTrials.Veeva

Menu

Optimization of an Automated Ultrasound Cardiac Guidance Tool

U

UltraSight

Status

Completed

Conditions

Ultrasound Therapy

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

Open-label, single-arm, prospective study. Subjects will undergo one session of 2D Transthoracic Echocardiogram (2D-TTE) ultrasound. The ultrasound will be performed by a trained sonographer.

Full description

The study will use a commercially available handheld imaging device (Philips Lumify transducer).

Primary Objective:

To acquire images of multiple transducer position, trajectories, and views, at different acoustic windows for capturing images and location relative to body and probe positions.

Enrollment

75 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age 18 years and above.
  2. Patients able to understand, read and sign the informed consent
  3. Patient willing to answer a short questionnaire

Exclusion criteria

  1. Pregnancy(females of childbearing potential will be tested with a urine pregnancy test prior to their inclusion in the study)
  2. Not willing or not able to sign an inform consent
  3. Physical limitation to maneuvering the probe on the body
  4. Unable to lie flat for study
  5. Patients experiencing a known or suspected acute cardiac event
  6. Patients with severe chest wall abnormalities
  7. Patients who have undergone pneumonectomy
  8. Patients whose anatomy does not lend itself to echocardiography

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems